News

CERo Therapeutics Holdings, Inc. (CERO) Doses First Patient in CER-1236 CAR-T AML Trial
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) has achieved a major milestone in the fight against acute myeloid leukemia ...
Grit Biotechnology Presents Clinical Breakthroughs at 2025 ASCO Annual Meeting
Grit Biotechnology Co., Ltd. ("Grit Bio"), a clinical-stage biotech pioneering novel immunotherapies announced today that ...
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...
Pharmaceutical Technology on MSN3d
FDA grants RMAT designation to AbelZeta’s CAR-T therapy
The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...
Clinical Trials Arena on MSN3d
BrainStorm Cell Therapeutics and Minaris partner on manufacturing NurOwn for trial
US-based biotechnology company BrainStorm Cell Therapeutics has partnered with contract development and manufacturing ...
Precision Medicine Online4d
EMA's CHMP Recommends Autolus' CAR T-Cell Therapy Aucatzyl for B-ALL
NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...
Newseria BIZNES5d
Breast Reconstruction Market Growth, Trends & Opportunities | Global Analysis 2025 | DataM Intelligence
The Global Breast Reconstruction Market is expected to reach at a CAGR of 6.4% during the forecast period (2024-2031). The Breast Reconstruction Market is growing rapidly, driven by rising breast ...
ahajournals.org5d
Bioengineering Human Tissues and the Future of Vascular Replacement
Traditional vascular grafts made of synthetic polymers, animal and cadaveric tissues, or autologous vasculature have been utilized for almost a century with well-characterized outcomes, leaving areas ...